REYNA CHAVARRI: Open Payments
NPI 1457005456 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 48 payments from 13 companies in 2025. Trend: 2023 $922 · 2024 $3,234 · 2025 $1,626
Food & beverage: $1,426Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $648 |
| UCB, Inc. | 3 | $251 |
| Amgen Inc. | 13 | $199 |
| AstraZeneca Pharmaceuticals LP | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 6 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| Lilly USA, LLC | 2 | $52 |
| ABBVIE INC. | 2 | $40 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| GENZYME CORPORATION | 1 | $31 |
Products named: TREMFYA, Bimzelx, ENBREL, SAPHNELO, COSENTYX, TALTZ, KEVZARA, RINVOQ.
Industry payments across TX — which companies pay providers there.
